> Behavioral testing showed that treated models performed significantly better on memory and recognition tasks.

"Treated models" - it sounds like they're trying really hard to hide the fact that this was all in mice. From the paper:

> Therefore, using a mouse model, this study investigated whether IN administration of hiPSC-NSC-EVs in late middle age can significantly reduce oxidative stress and curb microglia-mediated neuroinflammaging in the hippocampus.

Cool! But please be honest in your press releases.